Novonesis Statistics
Novonesis (NZM2) Stock Statistics & Valuation Metrics
Total Valuation
Novonesis has a market cap or net worth of EUR 27.46B. The enterprise value is EUR 215.58B.
- Market Cap
- EUR 27.46B
- Enterprise Value
- EUR 215.58B
Share Statistics
Novonesis has 414,555,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 414,555,050
- Owned by Insiders
- ―
- Owned by Institutions
- 16.77%
Financial Efficiency
Novonesis’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.36%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 3.36%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 345.42K
- Profits Per Employee
- 27.55K
- Employee Count
- 11,098
- Asset Turnover
- 0.25
- Inventory Turnover
- 2.81
Valuation Ratios
The current PE Ratio of Novonesis is 26.48. Novonesis’s PEG ratio is 1.52.
- PE Ratio
- 26.48
- PS Ratio
- 5.55
- PB Ratio
- 7.04
- Price to FCF
- 87.23
- Price to Operating Cash Flow
- 24.30
- PEG Ratio
- 1.52
Income Statement
In the last 12 months, Novonesis had revenue of 3.83B and earned 305.80M in profits. Earnings per share was 1.10.
- Revenue
- 3.83B
- Gross Profit
- 1.81B
- Operating Income
- 659.00M
- Pretax Income
- 417.10M
- Net Income
- 305.80M
- EBITDA
- 659.00M
- Earnings Per Share (EPS)
- 1.10
Cash Flow
In the last 12 months, operating cash flow was 2.57B and capital expenditures -771.53M, giving a free cash flow of 1.80B billion.
- Operating Cash Flow
- 2.57B
- Free Cash Flow
- 1.80B
- Free Cash Flow per Share
- 4.03
Dividends & Yields
Novonesis pays an annual dividend of ―, resulting in a dividend yield of 1.47%
- Dividend Per Share
- ―
- Dividend Yield
- 1.47%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.50%
- Earnings Yield
- 3.38%
Stock Price Statistics
- Beta
- 0.24
- 52-Week Price Change
- 7.71%
- 50-Day Moving Average
- 59.61
- 200-Day Moving Average
- 54.02
- Relative Strength Index (RSI)
- 44.22
- Average Volume (3m)
- 218
Important Dates
Novonesis upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 11, 2027
- Ex-Dividend Date
- ―
Financial Position
Novonesis as a current ratio of 1.73, with Debt / Equity ratio of 16.08%
- Current Ratio
- 1.73
- Quick Ratio
- 1.06
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- 2.30
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Novonesis has paid 111.30M in taxes.
- Income Tax
- 111.30M
- Effective Tax Rate
- 0.27
Enterprise Valuation
Novonesis EV to EBITDA ratio is 21.21, with an EV/FCF ratio of 41.65.
- EV to Sales
- 6.76
- EV to EBITDA
- 21.21
- EV to Free Cash Flow
- 41.65
- EV to Operating Cash Flow
- 30.42
Balance Sheet
Novonesis has EUR 256.50M in cash and marketable securities with EUR 1.70B in debt, giving a net cash position of -EUR 1.44B billion.
- Cash & Marketable Securities
- EUR 256.50M
- Total Debt
- EUR 1.70B
- Net Cash
- -EUR 1.44B
- Net Cash Per Share
- -EUR 3.48
- Tangible Book Value Per Share
- EUR 2.91
Margins
Gross margin is 54.56%, with operating margin of 26.37%, and net profit margin of 20.94%.
- Gross Margin
- 54.56%
- Operating Margin
- 26.37%
- Pretax Margin
- 25.96%
- Net Profit Margin
- 20.94%
- EBITDA Margin
- 34.84%
- EBIT Margin
- 26.54%
Analyst Forecast
The average price target for Novonesis is EUR 70.35, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 70.35
- Price Target Upside
- 18.23% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 6
- Revenue Growth Forecast
- 5.55%
- EPS Growth Forecast
- 24.50%
